Skip to main content

Table 1 Patient characteristics

From: Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

No. of patients

235

Age (years when treatments started)

  Range

3-82

  Medium

58

Sex (No. (%))

  Female

137 (58,3%)

  Male

98 (41,7%)

Cancer type (No. (%))

  Colorectal, intestinal and anal

42 (17,9%)

  Ovarian (also tubal)

35 (14,9%)

  Breast

29 (12,3%)

  Sarcomas

21 (8,9%)

  Pancreatic and papilla vater

20 (8,5%)

  Lung

18 (7,7%)

  Neuroblastoma

14 (6,0%)

  Prostate

12 (5,1%)

  Skin and melanomas

11 (4,7%)

  Liver and mesothelioma

9 (3,8%)

  Gastric

6 (2,6%)

  Biliary tract or cholangio

5 (2,1%)

  Urinary tract or bladder

4 (1,7%)

  Cervix and endometrial

3 (1,3%)

  Renal

3 (1,3%)

  Thyroid, thymus or parathydoid

2 (0,9%)

  Esophageal

1 (0,4%)